Prescription Opioid Cough and Cold Medicines: Drug Safety Communication – FDA Requires Labeling Changes
Murilo Freitas - 13:00, 10 de enero de 2018844
0
Risks of slowed or difficult breathing, misuse, abuse, addiction, overdose, and death with these medicines outweigh their benefits in patients younger than 18.